TNFRSF21 and Alzheimer disease: As cognitive preservation in patients with AD can be independent of Aβ clearance, future studies can focus on the impact of BEC-specific upregulation of DR6 in vivo, in order to determine whether this approach can protect BBB and cognitive function in the context of Aβ accumulation during AD progression.